Brian Malki, MD
Anesthesiology · Little Rock, ARNPI 1346620697
Payments from drug & device makers
What this record shows
This record is dominated by grants: $25,000 of the $29,475 with a category attached, or 84.8%. 26 manufacturers reported payments, led by Medtronic at 53.8% of the total. Reporting peaked in 2019 at $25,570 and has fallen 97.0% since, to $763 in 2025. Among anesthesiology clinicians in AR with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 161 payments — averaging $183.07 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medtronic$16K
- Boston Scientific$11K
- Collegium Pharmaceutical, Inc.$1K
- Abbott$546
- Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$399
- Nevro Corp.$225
- plus $784 from 20 others
What the payments were for
- Grants$25,00085%
- Food & beverage$4,47515%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medtronic(2 entities) | 27 | $15,844 |
| Boston Scientific | 11 | $10,510 |
| Collegium Pharmaceutical, Inc. | 60 | $1,167 |
| Abbott | 4 | $546 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 25 | $399 |
| Nevro Corp. | 6 | $225 |
| Nalu Medical, Inc. | 2 | $135 |
| Averitas Pharma Inc. | 2 | $130 |
| Stryker | 2 | $93 |
| Vertos Medical, Inc. | 1 | $88 |
| Lilly USA, LLC | 4 | $56 |
| Scilex Pharmaceuticals Inc. | 2 | $41 |
| Pacira Therapeutics, Inc. | 2 | $35 |
| Kerecis Limited | 1 | $21 |
| Spinal Simplicity, LLC | 1 | $20 |
| Teva Pharmaceuticals USA, Inc. | 1 | $18 |
| Vertex | 1 | $18 |
| Sun Pharmaceutical Industries Inc. | 1 | $18 |
| GRT US Holding, Inc. | 1 | $17 |
| SPR Therapeutics, Inc | 1 | $17 |
| AbbVie | 1 | $15 |
| Pfizer | 1 | $14 |
| Bioventus LLC | 1 | $14 |
| Redhill Biopharma Inc. | 1 | $14 |
| Biodelivery Sciences International, Inc. | 1 | $13 |
| VGI Medical, LLC | 1 | $8 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- SYNCHROMED$15,000
- SPECTRA WAVEWRITER$10,000
- ETERNA$275
- Proclaim IPG$271
- Senza$134
- Qutenza$106
- Nalu Neurostimulation System$100
- SUPERION$100
How this compares
$29,475 in reported general payments places this provider in the 95th percentile of 300 anesthesiology providers in Arkansas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 987 | $25,984 |
| Buprenorphine | 50 | $14,182 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 450 | $12,177 |
| BelbucaBuprenorphine Hcl | 38 | $7,999 |
| OxycontinOxycodone Hcl | 12 | $4,785 |
| Oxycodone Hcl | 274 | $4,182 |
| Xtampza ErOxycodone Myristate | 11 | $3,787 |
| Naloxone Hcl | 45 | $3,197 |
| Pregabalin | 155 | $3,089 |
| Gabapentin | 268 | $2,337 |
| Tizanidine Hcl | 217 | $2,326 |
| Methocarbamol | 155 | $1,486 |
| Morphine Sulfate ErMorphine Sulfate | 68 | $1,367 |
| Morphine Sulfate | 72 | $1,357 |
| Duloxetine Hcl | 114 | $1,352 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Collegium Pharmaceutical, Inc.Belbuca, Xtampza Er | $1,167 | $11,78649 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 300 anesthesiology providers in Arkansas.
Other anesthesiology in Little Rock
- Johnathan GoreeLittle Rock$513K
- Julius BaloghLittle Rock$245K
- Gregory SmithLittle Rock$55K
- Aparna JindalLittle Rock$10K
- Jarna ShahLittle Rock$10K
- Brian JansenLittle Rock$8K
- Jaleesa JacksonLittle Rock$4K
- Juan RomanLittle Rock$4K
- Felipe MedeirosLittle Rock$3K
- Rodney McCarverLittle Rock$3K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.